Background: HIV-exposed infants suffer high mortality in the first year of life, but accurate data on the burden of malaria are lacking. We evaluated the incidence of febrile illnesses and malaria in a birth cohort born to HIV-infected women living in a hyper-endemic area of rural Uganda where the incidence of malaria in a contemporaneous cohort of HIV-unexposed infants aged 6-12 months was over 5 episodes/person-year.
Methods: In the PROMOTE trial (NCT00993031), HIV-infected pregnant women were randomized to either efavirenz- or lopinavir- based therapy. Infants were given insecticide treated bednets at birth, cotrimoxazole prophylaxis at 6 weeks of age, and followed for all their health care needs in the study clinic until 12 months of age. All febrile episodes were evaluated with blood smears for malaria and if present, treated. Risk factors for malaria were assessed using generalized estimating equations.
Results: Of 361 infants born to 377 HIV-infected mothers and surviving beyond 24 hours, 19% were low birth weight (< 2500 gm), 17 were pre-term (< 37 weeks), and 34% had evidence of placental malaria by histopathology. In 305 patient-years (py) of follow up, there were 1561 febrile episodes (5.1/py) and 265 episodes of malaria (0.87/py). The incidence of febrile illnesses increased modestly after 4 months of age (Figure). In contrast, the incidence of malaria incidence increased dramatically over the first year of life (p<0.001, Figure) with only 2 episodes of malaria in infants under 2 months of age, neither of whom had started cotrimoxazole. The proportion of febrile illnesses that were malaria increased from < 1% at 0 -2 months of age to over 37% by 11-12 months of age. Low birth weight, prematurity, maternal study arm, and placental malaria were not significantly associated with malaria during the first year of life. There were no episodes of WHO-classified complicated malaria, 6 deaths (none from malaria), and 2 cases of HIV transmission.
Conclusions: HIV-exposed infants living in a hyper-endemic area who had access to cotrimoxazole prophylaxis and prompt malaria treatment experienced lower rates of malaria than HIV-unexposed infants, with no complicated malaria or malaria mortality. These results underscore the importance of accurate malaria testing and the consideration of non-malarial infectious etiologies in reducing the morbidity and mortality of HIV-exposed infants, especially those < 6 months of age.